K. K. Gangopadhyay, “Consensus of expert through Indian perspective on the fixed-dose combination dapagliflozin and linagliptin combination in type 2 diabetes mellitus: CONSEPDT study”, Int J Res Med Sci, vol. 14, no. 1, pp. 333–340, Dec. 2025.